Dr. Mazen Albeldawi, MD

Dr. Albeldawi practices at Physicians Regional Medical Center - Pine Ridge in Naples, Florida, part of Community Health Systems.

Dr. Albeldawi's NPI, 1811161680, was assigned on April 14, 2008. Dr. Albeldawi holds Florida license ME119815.

Dr. Albeldawi's primary practice is Physicians Regional Medical Center - Pine Ridge, at 6101 Pine Ridge Road, Naples, FL 34119 in Collier County. The practice phone is (239) 304-5145.

Dr. Albeldawi's primary practice is Physicians Regional Medical Center - Pine Ridge in Naples, Florida, part of Community Health Systems. Dr. Albeldawi is also affiliated with NCH Baker Hospital. The medical group on file is Meliora Healthcare. Dmand AI also links Dr. Albeldawi to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albeldawi practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Albeldawi's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Albeldawi is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Albeldawi's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Albeldawi treats.

CMS data shows 3,969 Medicare services from Dr. Albeldawi across 15 procedure codes in 2024, for 1,170 Medicare patients. Medicare paid $399,129 for them.

CMS counts 1,170 Medicare patients who saw Dr. Albeldawi in 2024. The largest group is 65 to 74, with 555 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 1% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Albeldawi's median patient age at 69, with 53% women.

In 2024, Dr. Albeldawi wrote 1,330 Medicare Part D claims for 486 patients. 86% of them were for generic drugs. CMS names the drug for 1,152 of them, across 26 drugs with 11 or more claims each, at $150,166 in total drug cost. In 2023, CMS named 1,062 claims across 19 drugs.

Dr. Albeldawi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Albeldawi as offering telehealth. CMS counts 537 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Albeldawi, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 21 papers to Dr. Albeldawi, published from 2010 to 2016. 2014 was the busiest year, with 7. The most frequent topics are Liver Transplantation, Cardiovascular Diseases and Colonoscopy. Dr. Albeldawi has published most often in Gastroenterol Rep (Oxf). Dr. Albeldawi's most frequent co-authors are Paresh P. Mehta, MD, Nizar N. Zein, MD and Jacek B. Cywinski, MD.

CMS Open Payments shows 104 general payments to Dr. Albeldawi from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Medtronic, Inc. paid the most, $1,147.

Dmand AI lists 2 awards for Dr. Albeldawi, most recently Castle Connolly Top Doctor in 2022. Dr. Albeldawi serves on American College of Gastroenterology.

Dr. Albeldawi is a member of ACG, ASGE and ASBP.

Dr. Albeldawi is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.